OAC
XFOR icon

OMERS Administration Corp’s X4 Pharmaceuticals XFOR Stock Holding History

OMERS Administration Corp’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$237K Sell
57,300
-51,900
-48% -$194K ﹤0.01% 884
2025
Q4 		$437K Buy
+109,200
New +$397K ﹤0.01% 706

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

OMERS Administration Corp's XFOR Position: Q1 2026 in Review

OMERS Administration Corp reduced its X4 Pharmaceuticals (XFOR) stake by 48% in Q1 2026, selling an estimated $194K and leaving 57,300 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

OMERS Administration Corp first reported a position in XFOR in Q4 2025 and has held it in 2 quarters since. The position peaked at $437K in Q4 2025. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • OMERS Administration Corp held 57,300 shares of X4 Pharmaceuticals worth $237K as of Q1 2026.
  • OMERS Administration Corp sold 51,900 X4 Pharmaceuticals shares in Q1 2026, an estimated $194K.
  • X4 Pharmaceuticals made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #884 holding.
  • OMERS Administration Corp first reported a position in X4 Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's X4 Pharmaceuticals position peaked at $437K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.